Protalix BioTherapeutics (AMEX:PLX) is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Protalix BioTherapeutics will report an earnings per share (EPS) of $0.04. The announcement from Protalix BioTherapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It’s worth noting for new investors that guidance can be a key determinant of stock price movements. Performance in Previous EarningsIn the prev…